An update of respiratory cancer and occupational exposure to arsenicals.
Mortality was updated through 1982 for 611 arsenic-exposed employees originally studied through 1973. In the earlier report, total mortality was observed to have been below the comparable U.S. population; however, mortality was significantly elevated for respiratory cancer. The focus of the update was on respiratory cancer and of special interest was whether the risk of respiratory cancer remained in excess for individuals alive as of the end of the last study. In the update, 9 additional respiratory cancers were observed subsequent to 1973, the end of the follow-up in the original study, versus 7.8 expected. The risk ratio for the time-interval 1974-1982 (standardized mortality ratio SMR = 116) was diminished compared to that reported in the original study (SMR = 330). When the entire study period was analyzed, the risk of respiratory cancer did not appear to decline with interval since exposure cessation. Analyses by duration of arsenic exposure and interval since first exposure did not reveal any obvious dose-response relationships.
Sobel
W
W
Department of Epidemiology, Dow Chemical Company, Midland, MI 48674.
Bond
G G
GG
Baldwin
C L
CL
Ducommun
D J
DJ
D001151:Arsenic / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009784:Occupational Diseases / Q000139:chemically induced* / Q000401:mortality; D012142:Respiratory Tract Neoplasms / Q000139:chemically induced* / Q000401:mortality; D012307:Risk Factors
D001151:Arsenic